Barclays’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-7
| Closed | – | – | 4011 |
|
|
2019
Q4 | $0 | Sell |
7
-9
| -56% | – | ﹤0.01% | 4347 |
|
|
2019
Q3 | $0 | Sell |
16
-8,598
| -100% | – | ﹤0.01% | 4518 |
|
|
2019
Q2 | $146K | Buy |
8,614
+7,449
| +639% | +$126K | ﹤0.01% | 3378 |
|
|
2019
Q1 | $39K | Buy |
1,165
+1,159
| +19,317% | +$38.8K | ﹤0.01% | 3748 |
|
|
2018
Q4 | $0 | Sell |
6
-3,509
| -100% | – | ﹤0.01% | 4499 |
|
|
2018
Q3 | $216K | Buy |
3,515
+574
| +20% | +$35.3K | ﹤0.01% | 3031 |
|
|
2018
Q2 | $217K | Buy |
2,941
+1,621
| +123% | +$120K | ﹤0.01% | 2707 |
|
|
2018
Q1 | $86K | Sell |
1,320
-755
| -36% | -$49.2K | ﹤0.01% | 3236 |
|
|
2017
Q4 | $174K | Sell |
2,075
-2,853
| -58% | -$239K | ﹤0.01% | 2721 |
|
|
2017
Q3 | $569K | Buy |
4,928
+4,084
| +484% | +$472K | ﹤0.01% | 1843 |
|
|
2017
Q2 | $99K | Sell |
844
-744
| -47% | -$87.3K | ﹤0.01% | 2774 |
|
|
2017
Q1 | $196K | Buy |
1,588
+341
| +27% | +$42.1K | ﹤0.01% | 2519 |
|
|
2016
Q4 | $170K | Buy |
1,247
+1,225
| +5,568% | +$167K | ﹤0.01% | 2372 |
|
|
2016
Q3 | $4K | Sell |
22
-579
| -96% | -$105K | ﹤0.01% | 3480 |
|
|
2016
Q2 | $78K | Buy |
601
+583
| +3,239% | +$75.7K | ﹤0.01% | 2434 |
|
|
2016
Q1 | $2K | Sell |
18
-30
| -63% | -$3.33K | ﹤0.01% | 3244 |
|
|
2015
Q4 | $9K | Buy |
48
+44
| +1,100% | +$8.25K | ﹤0.01% | 2838 |
|
|
2015
Q3 | $1K | Sell |
4
-12
| -75% | -$3K | ﹤0.01% | 3795 |
|
|
2015
Q2 | $3K | Buy |
16
+5
| +45% | +$938 | ﹤0.01% | 3836 |
|
|
2015
Q1 | $3K | Buy |
+11
| New | +$3K | ﹤0.01% | 3840 |
|